Os Clinic

Os Clinic company information, Employees & Contact Information

Explore related pages

Related company profiles:

As a group of internationally acclaimed medical professionals, OS Clinic (Orthopaedic and Maxillofacial Specialists) prides itself on two things: innovation and outstanding care. We understand that undergoing medical treatment can be daunting, which is why our mission is to minimise pain and to get patients back to full fitness as quickly as possible. With the support of an exceptional multi-disciplinary team, patients are guaranteed a quick diagnosis and a personalised care plan, regardless of whether they’re being treated for a sports injury or their condition is down to wear and tear. As leaders in their respective fields, our consultants are pioneers and educators. They are key players in training the next generation of experts; and they’ve helped to develop several of today’s revolutionary techniques too. Of course, we’re proud of our global success, but it’s what this means for our patients’ outcomes that really counts. With access to the world’s most advanced surgical and non-surgical techniques, at OS Clinic we always examine every treatment option. We know that less invasive procedures are highly effective, and can reduce recovery times, which is why we only perform joint replacement surgery as the last – not the first – resort. With easily accessible clinics in Harley Street and across London, there are no waiting lists, and patients can self-refer by emailing or calling for an appointment. OS Clinic treats self-funded patients and those with private health insurance, as well as providing a full service for international patients, overseeing every aspect of their care.

Company Details

Employees
36
Founded
-
Address
45 Queen Anne Street, London,england W1g 9jf,united Kingdom
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
Website
os.clinic
HQ
London, England
Looking for a particular Os Clinic employee's phone or email?

Os Clinic Questions

News

A New Era for Cardio-Oncology - Cleveland Clinic

A New Era for Cardio-Oncology Cleveland Clinic

Well, well, well: brands to keep us feeling fine in 2025 - The Times

Well, well, well: brands to keep us feeling fine in 2025 The Times

Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer - Nature

Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer Nature

Diego Sadler, MD, Elected Chair of Cardio-Oncology Leadership Council With American College of Cardiology - Cleveland Clinic Newsroom

Diego Sadler, MD, Elected Chair of Cardio-Oncology Leadership Council With American College of Cardiology Cleveland Clinic Newsroom

Car Seat Safety Clinic - Lake Oswego City

Car Seat Safety Clinic Lake Oswego City

Lutetium-177 shows significant rPFS benefit for metastatic prostate cancer - Mayo Clinic

Lutetium-177 shows significant rPFS benefit for metastatic prostate cancer Mayo Clinic

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50% | Journal of Clinical Oncology - ASCO Publications

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50% | Journal of Clinical Oncology ASCO Publications

OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS - Business Wire

OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS Business Wire

Defining the clinical course of multiple sclerosis - Neurology® Journals

Defining the clinical course of multiple sclerosis Neurology® Journals

Find a Doctor - UChicago Medicine

Find a Doctor UChicago Medicine

Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma - Nature

Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma Nature

Sleep apnea - Symptoms and causes - Mayo Clinic

Sleep apnea - Symptoms and causes Mayo Clinic

Olson Pediatric Clinic - Lake Oswego City

Olson Pediatric Clinic Lake Oswego City

Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience | Blood Cancer Journal - Nature

Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience | Blood Cancer Journal Nature

Tumor burden in EGFR-mutant NCSCLC impacts overall survival - Cleveland Clinic

Tumor burden in EGFR-mutant NCSCLC impacts overall survival Cleveland Clinic

Molecular determinants of sotorasib clinical efficacy in KRAS - Nature

Molecular determinants of sotorasib clinical efficacy in KRAS Nature

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and - Nature

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and Nature

Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial - Nature

Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial Nature

One thousand patients with essential thrombocythemia: the Mayo Clinic experience | Blood Cancer Journal - Nature

One thousand patients with essential thrombocythemia: the Mayo Clinic experience | Blood Cancer Journal Nature

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial - Nature

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial Nature

NYU Langone Orthopedic Center - NYU Langone Health

NYU Langone Orthopedic Center NYU Langone Health

Time to Treat is Increasing, Associated with Worsened Survival - Cleveland Clinic

Time to Treat is Increasing, Associated with Worsened Survival Cleveland Clinic

Study Identifies Prognostic Subgroups in Cutaneous Squamous Cell Carcinoma - Cleveland Clinic

Study Identifies Prognostic Subgroups in Cutaneous Squamous Cell Carcinoma Cleveland Clinic

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer - The New England Journal of Medicine

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer The New England Journal of Medicine

Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts | Journal of Clinical Oncology - ASCO Publications

Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts | Journal of Clinical Oncology ASCO Publications

Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers - Nature

Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers Nature

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial - Nature

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial Nature

Six-year experience of Australia’s first dedicated cancer of unknown primary clinic | British Journal of Cancer - Nature

Six-year experience of Australia’s first dedicated cancer of unknown primary clinic | British Journal of Cancer Nature

Updates in the Evaluation and Management of Breast Cancer - Mayo Clinic Proceedings

Updates in the Evaluation and Management of Breast Cancer Mayo Clinic Proceedings

The Ins and Outs of I&Os - Cleveland Clinic

The Ins and Outs of I&Os Cleveland Clinic

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial - Nature

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial Nature

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial | Journal of Clinical Oncology - ASCO Publications

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial | Journal of Clinical Oncology ASCO Publications

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer - The New England Journal of Medicine

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer The New England Journal of Medicine

Lake Grove Family Medical Clinic - Lake Oswego City

Lake Grove Family Medical Clinic Lake Oswego City

Phase II Trial Evaluates Safety of Pembrolizumab plus SurVaxM in Recurrent Glioblastoma - Cleveland Clinic

Phase II Trial Evaluates Safety of Pembrolizumab plus SurVaxM in Recurrent Glioblastoma Cleveland Clinic

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts | Blood Cancer Journal - Nature

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts | Blood Cancer Journal Nature

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC - The New England Journal of Medicine

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC The New England Journal of Medicine

Deciphering Leg Pain in Children: What’s Normal and What’s Not? - Cleveland Clinic

Deciphering Leg Pain in Children: What’s Normal and What’s Not? Cleveland Clinic

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy - BMC Cancer

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy BMC Cancer

Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma - Nature

Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma Nature

Assessing Outcomes for Patients with Uveal Melanoma Metastatic to the Liver - Cleveland Clinic

Assessing Outcomes for Patients with Uveal Melanoma Metastatic to the Liver Cleveland Clinic

KEYNOTE-426: Pembrolizumab + Axitinib or Sunitinib Alone for Advanced Renal Cell Carcinoma? - Cleveland Clinic

KEYNOTE-426: Pembrolizumab + Axitinib or Sunitinib Alone for Advanced Renal Cell Carcinoma? Cleveland Clinic

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma | Blood Cancer Journal - Nature

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma | Blood Cancer Journal Nature

Listeria Monocytogenes Endophthalmitis: A Case Study - Cleveland Clinic

Listeria Monocytogenes Endophthalmitis: A Case Study Cleveland Clinic

Top Os Clinic Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant